$1.20 +0.04 (%) Zogenix Inc - NASDAQ

Dec. 22, 2014 | 04:00 PM

Partner Headlines

  1. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  2. Zogenix Reports Zohydro ER Shows Sustained 12-Hour Pain Relief

    Benzinga | Sep. 2, 2014 | 07:35AM EST
  3. Zohydro Gains Massachusetts Approval, Acts As Minor Catalyst For Zogenix

    Benzinga | Aug. 5, 2014 | 14:24PM EST
  4. Zogenix Announces Departure of Chief Commercial Officer, Scott Shively

    Benzinga | Aug. 1, 2014 | 16:05PM EST
  5. Zogenix Announces David Brushwood, J.D., R.Ph., Joins External Safe Use Board

    Benzinga | Jul. 17, 2014 | 08:31AM EST
  6. Morning Market Movers

    Benzinga | Jul. 2, 2014 | 09:38AM EST
  7. Zogenix Provides Update On Development Of Abuse Deterrent Formulations Of Zohydro ER

    Benzinga | Jul. 2, 2014 | 07:36AM EST
  8. Benzinga's Top #PreMarket Losers

    Benzinga | May. 9, 2014 | 08:21AM EST
  9. Morning Market Movers

    Benzinga | Apr. 24, 2014 | 09:42AM EST
  10. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 24, 2014 | 08:11AM EST
  11. Zogenix Announces Sale of SUMAVEL DosePro Migraine Therapy to Endo International for $85M, Up to $20M Milestone Payments

    Benzinga | Apr. 24, 2014 | 07:31AM EST
  12. Zogenix Responds to Governor's Action Singling Out Zohydro ER in Massachusetts

    Benzinga | Apr. 23, 2014 | 07:34AM EST
  13. Morning Market Movers

    Benzinga | Apr. 16, 2014 | 09:38AM EST
  14. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 16, 2014 | 08:14AM EST
  15. UPDATE: Zogenix-Says Court Granted Temporary Restraining Order Preventing Implementation of Massachusetts Ban of Zohydro ER Extended-Release Capsules =8-K

    Benzinga | Apr. 16, 2014 | 06:10AM EST
  16. UPDATE: Zogenix Announces Ruling Preventing Implementation of MA. Gov.'s Order Which Prevented Access to Zohydro ER

    Benzinga | Apr. 15, 2014 | 16:02PM EST
  17. Morning Market Movers

    Benzinga | Apr. 9, 2014 | 09:39AM EST
  18. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 9, 2014 | 08:09AM EST
  19. Zogenix Appoints James Breitmeyer to Its Board of Directors

    Benzinga | Mar. 26, 2014 | 08:30AM EST
  20. Morning Losers for Friday, March 14, 2014

    Benzinga | Mar. 14, 2014 | 10:10AM EST
  21. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 14, 2014 | 08:21AM EST
  22. Morning Movers for March 12th, 2014

    Benzinga | Mar. 12, 2014 | 10:15AM EST
  23. Morning Market Losers

    Benzinga | Mar. 12, 2014 | 09:49AM EST
  24. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 12, 2014 | 08:47AM EST
  25. Zogenix Reports Q4 Earnings; Shares Soar 5%

    Benzinga | Mar. 5, 2014 | 18:27PM EST
  26. After-Hours Movers Mar. 5, 2014: ERII, PXLW, BIOD, SEED Higher, DVAX, LYV Lower

    Benzinga | Mar. 5, 2014 | 18:15PM EST
  27. Morning Losers for Mar. 3, 2014: YNDX, CETV, AKRX, CPST, LIVE

    Benzinga | Mar. 3, 2014 | 10:43AM EST
  28. Mornings Movers for Feb. 27, 2014: PEIX, JCP, SYMX, CIE, SHLD, BBY Higher, INO, NDLS, HK, CY, DYAX Lower

    Benzinga | Feb. 27, 2014 | 09:43AM EST
  29. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 3, 2014 | 08:36AM EST
  30. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 17, 2013 | 08:19AM EST
  31. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 14, 2013 | 08:11AM EST
  32. UPDATE: Oppenheimer Upgrades Zogenix Following Zohydro Approval

    Benzinga | Nov. 14, 2013 | 07:09AM EST
  33. Zogenix Prices 26.66M Share Offering at $2.25/Share

    Benzinga | Nov. 5, 2013 | 19:52PM EST
  34. US Stock Futures Up Ahead Of Factory Orders Data

    Benzinga | Nov. 4, 2013 | 07:30AM EST
  35. Zogenix Announces $60M Common Stock Offering

    Benzinga | Nov. 4, 2013 | 07:08AM EST
  36. UPDATE: Stifel Upgrades Zogenix Following Approval of Zohydro

    Benzinga | Oct. 29, 2013 | 09:11AM EST
  37. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 28, 2013 | 08:14AM EST
  38. Morning Market Movers

    Benzinga | Oct. 2, 2013 | 09:59AM EST
  39. Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB

    GuruFocus | Dec. 24, 2012 | 04:56AM EST
  40. Zogenix Shares Plunge 52% on FDA Panel's Turn-Down of Painkiller

    YCharts | Dec. 10, 2012 | 09:07AM EST
  41. UPDATE: Stifel Nicolaus Downgrades Zogenix to Hold Following FDA Panel

    Benzinga | Dec. 10, 2012 | 04:07AM EST
  42. UPDATE: Oppenheimer Downgrades Zogenix to Perform Following Negative Panel

    Benzinga | Dec. 10, 2012 | 03:21AM EST
  43. Morning Market Losers

    Benzinga | Dec. 10, 2012 | 03:02AM EST
  44. Zogenix to Host Conference Call Following FDA Panel Meeting, Will Be at 6:30PM

    Benzinga | Dec. 7, 2012 | 00:40AM EST
  45. Zogenix Announces New Chief Commercial Officer

    Benzinga | Nov. 26, 2012 | 00:35AM EST
  46. Zogenix Says FDA Panel Will Review Zohydro on Dec. 7th

    Benzinga | Nov. 8, 2012 | 02:30AM EST
  47. UPDATE: Stifel Nicolaus Reduces PT to $6 on Zogenix on Dilutive Deal

    Benzinga | Aug. 9, 2012 | 05:40AM EST
  48. Zogenix Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

    Benzinga | Jul. 23, 2012 | 10:13AM EST
  49. Zogenix Pops on FDA Acceptance for Review of Zohydro ER NDA

    Benzinga | Jul. 16, 2012 | 05:13AM EST
  50. Conmed Healthcare Management, Zogenix Among Stocks Gapping Up Monday

    FoxBusiness | Jul. 16, 2012 | 04:31AM EST
Trading Center